HomeCardiovascular Systems

Cardiovascular Systems

Cardiovascular Systems Announces U.S. Commercial Launch of JADE Over-the-Wire Non-Compliant Peripheral Balloon Catheters

JADE is an OTW balloon catheter for PTA in the peripheral vasculature, including obstructed native arteries and synthetic arteriovenous dialysis fistulae, as well as for post-dilatation of balloon expandable and self-expanding stents.

Journal of Medical Economics Article Demonstrates Economic Benefits of Cardiovascular Systems Orbital Atherectomy in the Treatment of Peripheral Artery Disease

LIBERTY 360° represents the largest, contemporary real-world experience with various endovascular strategies across the full range of Rutherford Class (RC) patients, including those with critical limb ischemia, the most compromised RC6 patients.

Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC

Peripheral support catheters are used during peripheral vascular intervention procedures for guidewire support to enable lesion crossing, as well as for guidewire exchanges.

WIRION Embolic Protection System – 1st Patients Treated Reports Cardiovascular Systems, Inc.

WIRION Embolic Protection System is a distal embolic protection filter used to capture thrombus and debris that can be associated with all types of peripheral vascular intervention procedures, including atherectomy.

The Diamondback 360 Coronary Orbital Atherectomy System Receives CE Mark

Diamondback 360 Coronary Orbital atherectomy system is the market-leading coronary atherectomy device in the United States. Diamondback combines differential sanding and pulsatile forces to treat all calcium modalities, including nodular, eccentric (irregular) and concentric (ring-shaped).

Diamondback 360 Coronary Orbital Atherectomy System Large Study Demonstrates Exceptional Safety and High Procedural Success: Reported at TCT Connect 2020

Diamondback 360 Coronary Orbital Atherectomy System Large Study shows exceptional safety and high procedural success in 519 patients with severely calcified cardiac disease who were treated with orbital atherectomy prior to stent deployment.

Cardiovascular Systems Announces Presentation of Data From Large Coronary Orbital Atherectomy Study at the TCT Connect 2020 Conference

This is a large retrospective observational study from a high volume, tertiary center treating complex severely calcified de novo coronary lesions that underwent lesion preparation with OAS before stent deployment.

Cardiovascular Systems Presents REACH PVI Study at the New Cardiovascular Horizons Conference

REACH PVI study prospectively evaluated acute clinical outcomes of orbital atherectomy via transradial access for the treatment of peripheral artery disease (PAD) in lower extremity lesions.